MedPath

Effect of supplementation in treatment of women with cervical intraepithelial neoplasia 2 and 3

Phase 3
Conditions
C53.9
Cervical intraepithelial neoplasia 2 and 3.
Cervix uteri, unspecified
Registration Number
IRCT201601045623N65
Lead Sponsor
Vice chancellor for research, Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
58
Inclusion Criteria

Women with cervical intraepithelial neoplasia 2 and 3
Aged 25 to 65 years old

Exclusion Criteria

Women who had a history of cervical cancer or other cancers of the lower genital tract
History of hysterectomy or destructive therapy of the cervix
Pregnant women

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recurrence. Timepoint: Six months after intervention. Method of measurement: Colposcopy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath